Redwood Investments, LLC Castle Biosciences Inc Transaction History

Redwood Investments, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 15, 2022	SELL	$16.0 - $45.99 $6.01 Million - $17.3 Million	-375,892 Closed	0 $0
Q1 2022 Apr 20, 2022	BUY	$33.17 - $46.98 $6.7 Million - $9.49 Million	202,099 Added 116.29%	375,892 $16.9 Million
Q4 2021 Feb 03, 2022	SELL	$39.06 - $67.58 $72,964 - $126,239	-1,868 Reduced 1.06%	173,793 $7.45 Million
Q3 2021 Oct 19, 2021	SELL	$60.13 - $77.6 $651,207 - $840,407	-10,830 Reduced 5.81%	175,661 $11.7 Million
Q2 2021 Aug 02, 2021	SELL	$50.07 - $76.78 $8,561 - $13,129	-171 Reduced 0.09%	186,491 $13.7 Million
Q1 2021 May 17, 2021	SELL	$58.92 - $97.33 $7.45 Million - $12.3 Million	-126,430 Reduced 40.38%	186,662 $12.8 Million
Q4 2020 Feb 05, 2021	SELL	$43.6 - $73.05 $1.77 Million - $2.96 Million	-40,524 Reduced 11.46%	313,092 $21 Million
Q3 2020 Nov 13, 2020	BUY	$38.47 - $52.03 $11 Million - $14.9 Million	287,087 Added 431.52%	353,616 $18.2 Million
Q2 2020 Aug 03, 2020	BUY	$27.28 - $43.01 $1.81 Million - $2.86 Million	66,529 New	66,529 $2.51 Million

201

24.5M

303K

30.3K

Ticker CSTL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 26,297,000
Market Cap $724M
Description
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...

Get notified when there are updates to the investment portfolio of Redwood Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Redwood Investments, LLC with notifications on news.